![David N. Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Lloyd Segal | M | 60 |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 years |
John M. Langstaff | M | - |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 years |
Dirk Alkema | M | - |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 17 years |
Michael Churchill-smith | M | - |
McGill University
| 37 years |
Nicolas Matziorinis | M | - |
McGill University
| 36 years |
Ian Mumford | M | - |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 years |
Johan Vandersande | M | - |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 years |
Keith Tucker | M | - |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Nicola Urbani | M | - |
McGill University
| 11 years |
Steve Satov | M | - |
McGill University
| 6 years |
Gillian Holcroft | F | - |
McGill University
| 4 years |
Lance Eckel | M | - |
McGill University
| 4 years |
Adam Shine | M | - |
McGill University
| 7 years |
Laurence Nicole Mengin de Loyer | F | 56 |
McGill University
| 4 years |
Nicholas Green | M | 60 |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 9 years |
Thomas Wellner | M | 59 |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 3 years |
Luigi Fraquelli | M | - |
McGill University
| 6 years |
Ravila Gupta | F | 60 |
McGill University
| 6 years |
Warren Clamen | M | 58 |
McGill University
| 4 years |
Nicole Crawford | F | - |
McGill University
| 4 years |
Dean Larson | M | - |
McGill University
| 4 years |
Carole Cohen-Perez | F | - |
McGill University
| 4 years |
Christian Drapeau | M | - |
McGill University
| 4 years |
Riccardo Gregory Magini | M | - |
McGill University
| 4 years |
Michael Stewart Shunock | M | - |
McGill University
| 4 years |
David Neuburger | M | 65 |
McGill University
| 4 years |
Yoke Keong Yong | M | 64 |
McGill University
| 2 years |
Clifford Minn Rhee | M | 56 |
McGill University
| 4 years |
Rima Qureshi | F | 59 |
McGill University
| 4 years |
Peter G. Wilson | M | 61 |
McGill University
| 4 years |
Fred Harding | M | - |
McGill University
| 4 years |
Colinda Parent | F | - |
McGill University
| 4 years |
Trevor Boyd | M | - |
McGill University
| 1 years |
Kendrick C. Fong | M | - |
McGill University
| 4 years |
Adam Berger | M | - |
McGill University
| 4 years |
Hugh Macdonnell | M | - |
McGill University
| 4 years |
James Reid | M | - |
McGill University
| 4 years |
Hiu Fung Pang | M | 54 |
McGill University
| 4 years |
Ji Ye Mao | M | 61 |
McGill University
| 2 years |
Frank Tomaselli | M | 60 |
McGill University
| 4 years |
Ian Burney | M | - |
McGill University
| 4 years |
Alexander Rothwell | M | - |
McGill University
| 4 years |
Anne T. Kuriakose | M | - |
McGill University
| 4 years |
Natalie Piccinin | F | 59 |
McGill University
| 3 years |
Rodney Findley | M | - |
McGill University
| 4 years |
Guy Lafond | M | - |
McGill University
| 4 years |
Sheryl L. Newman | F | - |
McGill University
| 4 years |
Manon Plante | F | - |
McGill University
| 4 years |
Thomas Folinsbee | M | 57 |
McGill University
| 4 years |
Marc Olivier | M | - |
McGill University
| 3 years |
Danny Grant | M | - |
McGill University
| 11 years |
Ann Martin | F | - |
McGill University
| 2 years |
Hidekazu Horikoshi | M | 62 |
McGill University
| 2 years |
Daniel Dorey | M | 64 |
McGill University
| 2 years |
Guo Hua Chen | M | 60 |
McGill University
| 1 years |
Nadine Block | F | - |
McGill University
| 2 years |
Chris Kwan | M | - |
McGill University
| 4 years |
Scott Jones | M | 68 |
McGill University
| 4 years |
George Saroglou | M | 59 |
McGill University
| 4 years |
Colin Osborne | M | 59 |
McGill University
| 4 years |
John Saabas | M | - |
McGill University
| 3 years |
Brent Lokash | M | 56 |
McGill University
| 4 years |
Elias Georges | M | - |
McGill University
| 3 years |
Bertrand M. Millot | M | - |
McGill University
| 2 years |
Nelson Gentiletti | M | 62 |
McGill University
| 3 years |
Laurent Hallé | M | - |
McGill University
| 3 years |
Dino Rambidis | M | - |
McGill University
| 1 years |
Bernard Poznanski | M | 66 |
McGill University
| 3 years |
Tim N. Foote | M | - |
McGill University
| 4 years |
Lorne Abony | M | 55 |
McGill University
| 4 years |
James Wallace MacGregor | M | - |
McGill University
| 4 years |
Sébastien Rhéaume | M | - |
McGill University
| 4 years |
Mitchell Garber | M | 59 |
McGill University
| 4 years |
Anthony Gerstein | M | 55 |
McGill University
| 4 years |
Tim Hylton | M | 56 |
McGill University
| 4 years |
Christine Jai Poole | F | - |
McGill University
| 3 years |
Elliot Cooperstone | M | 62 |
McGill University
| 3 years |
Spiro Plagakis | M | - |
McGill University
| 4 years |
H. Norton | M | 63 |
McGill University
| 3 years |
Kenneth S. Adessky | M | 60 |
McGill University
| 3 years |
Peter Winkley | M | - |
Therapure Biopharma, Inc.
![]() Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 1 years |
Enrique Julian Joseph Bernard Lõpez de Mesa | M | 60 |
McGill University
| 4 years |
Bradley Semmelhaack | M | - |
McGill University
| 4 years |
Courtney Manning Oldrin | F | - |
McGill University
| 4 years |
Simon Lussier | M | - |
McGill University
| 4 years |
Paolo Boni | M | - |
McGill University
| 4 years |
Anne Martin-Vachon | F | 62 |
McGill University
| 2 years |
Denis Fragias | M | - |
McGill University
| 4 years |
Azam Dawood | M | - |
McGill University
| 4 years |
Peter Cashin | M | 68 |
McGill University
| 1 years |
James W. G. Turner | M | 59 |
McGill University
| 4 years |
Mark Pruzanski | M | 56 |
McGill University
| 4 years |
Christopher Reynolds | M | 60 |
McGill University
| 4 years |
Trent Mell | M | 54 |
McGill University
| 4 years |
Marc Lemieux | M | - |
McGill University
| 3 years |
Silvio Marsili | M | - |
McGill University
| 2 years |
Craig Leon | M | 56 |
McGill University
| 4 years |
Patrick Gagnon | M | 61 |
McGill University
| 4 years |
Sharon Langshur | M | - |
McGill University
| 4 years |
Prav Pillay | M | - |
McGill University
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David N. Bell
- Personal Network